A Probabilistic Framework for the Reference Dose (Probabilistic RfD)

Determining the probabilistic limits for the uncertainty factors used in the derivation of the Reference Dose (RfD) is an important step toward the goal of characterizing the risk of noncarcinogenic effects from exposure to environmental pollutants. If uncertainty factors are seen, individually, as “upper bounds†on the dose†scaling factor for sources of uncertainty, then determining comparable upper bounds for combinations of uncertainty factors can be accomplished by treating uncertainty factors as distributions, which can be combined by probabilistic techniques. This paper presents a conceptual approach to probabilistic uncertainty factors based on the definition and use of RfDs by the US. EPA. The approach does not attempt to distinguish one uncertainty factor from another based on empirical data or biological mechanisms but rather uses a simple displaced lognormal distribution as a generic representation of all uncertainty factors. Monte Carlo analyses show that the upper bounds for combinations of this distribution can vary by factors of two to four when compared to the fixed†value uncertainty factor approach. The probabilistic approach is demonstrated in the comparison of Hazard Quotients based on RfDs with differing number of uncertainty factors.

[1]  D. Barnes,et al.  Reference dose (RfD): description and use in health risk assessments. , 1988, Regulatory toxicology and pharmacology : RTP.

[2]  E J Calabrese,et al.  Lack of total independence of uncertainty factors (UFs): implications for the size of the total uncertainty factor. , 1993, Regulatory toxicology and pharmacology : RTP.

[3]  E J Calabrese,et al.  Improved method for selection of the NOAEL. , 1994, Regulatory toxicology and pharmacology : RTP.

[4]  Max Henrion,et al.  Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk and Policy Analysis , 1990 .

[5]  R J Kavlock,et al.  Benchmark Dose Workshop: criteria for use of a benchmark dose to estimate a reference dose. , 1995, Regulatory toxicology and pharmacology : RTP.

[6]  W Leisenring,et al.  Statistical properties of the NOAEL. , 1992, Regulatory toxicology and pharmacology : RTP.

[7]  R C Hertzberg,et al.  A Statistical Model for Species Extrapolation Using Categorical Response Data , 1985, Toxicology and industrial health.

[8]  R L Sielken,et al.  Assessment of safety/risk of chemicals: inception and evolution of the ADI and dose-response modeling procedures. , 1991, Toxicology letters.

[9]  I W Davidson,et al.  Biological basis for extrapolation across mammalian species. , 1986, Regulatory toxicology and pharmacology : RTP.

[10]  D W Gaylor,et al.  Incidence of developmental defects at the no observed adverse effect level (NOAEL). , 1992, Regulatory toxicology and pharmacology : RTP.

[11]  M J Small,et al.  Deriving allowable daily intakes for systemic toxicants lacking chronic toxicity data. , 1987, Regulatory toxicology and pharmacology : RTP.

[12]  C. P. Carpenter,et al.  Relationship between single-peroral, one-week, and ninety-day rat feeding studies. , 1969, Toxicology and applied pharmacology.

[13]  J. Hoekstra,et al.  Alternatives for the no‐observed‐effect level , 1993 .

[14]  Bruce D. Naumann,et al.  Scientific basis for uncertainty factors used to establish occupational exposure limits for pharmaceutical active ingredients , 1995 .

[15]  R. O. Gilbert.  Statistical Methods for Environmental Pollution Monitoring , 1987 .

[16]  D W Gaylor,et al.  Issues in qualitative and quantitative risk analysis for developmental toxicology. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[17]  E J Calabrese,et al.  Uncertainty factors and interindividual variation. , 1985, Regulatory toxicology and pharmacology : RTP.

[18]  M L Dourson,et al.  Regulatory history and experimental support of uncertainty (safety) factors. , 1983, Regulatory toxicology and pharmacology : RTP.

[19]  C C Travis,et al.  On the use of 0.75 as an interspecies scaling factor. , 1992, Risk analysis : an official publication of the Society for Risk Analysis.

[20]  K S Crump,et al.  A new method for determining allowable daily intakes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[21]  J. Aitchison,et al.  The Lognormal Distribution. , 1958 .

[22]  C C Travis,et al.  Interspecific scaling of toxicity data. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[23]  D Hattis,et al.  Human interindividual variability--a major source of uncertainty in assessing risks for noncancer health effects. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.

[24]  A. Fletcher,et al.  Drug Safety Tests and Subsequent Clinical Experience , 1978, Journal of the Royal Society of Medicine.

[25]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[26]  John L. Adgate,et al.  Subchronic to chronic exposure extrapolation: Toxicologic evidence for a reduced uncertainty factor , 1995 .

[27]  W Slob,et al.  Conversion factors estimating indicative chronic no-observed-adverse-effect levels from short-term toxicity data. , 1996, Regulatory toxicology and pharmacology : RTP.

[28]  D W Gaylor,et al.  The use of safety factors for controlling risk. , 1983, Journal of toxicology and environmental health.

[29]  M L Dourson,et al.  On Reference Dose (RFD) and Its Underlying Toxicity Data Base , 1992, Toxicology and industrial health.

[30]  C. S. Weil,et al.  Safety Evaluation of Chemicals, Relationship between Short-and Long-Term Feeding Studies in Designing an Effective Toxicity Test , 1963 .

[31]  M L Dourson,et al.  An Approach for Modeling Noncancer Dose Responses with an Emphasis on Uncertainty , 1997, Risk analysis : an official publication of the Society for Risk Analysis.

[32]  A. Renwick.  Data-derived safety factors for the evaluation of food additives and environmental contaminants. , 1993, Food additives and contaminants.

[33]  D G Hoel.  Statistical approaches to toxicological data. , 1979, Environmental health perspectives.

[34]  Statistical uncertainty in the no-observed-adverse-effect level , 1989 .

[35]  D Hattis,et al.  Human variability in susceptibility to toxic chemicals--a preliminary analysis of pharmacokinetic data from normal volunteers. , 1987, Risk analysis : an official publication of the Society for Risk Analysis.